WS #12353
Abbott reports solid Q2 beat-and-raise with revenue up 13% YoY, driven by Medical Devices and Cancer Diagnostics; raises FY26 EPS guidance.
Abbott Laboratories Q2 Beat-and-Raise
Abbott reports solid Q2 beat-and-raise with revenue up 13% YoY, driven by Medical Devices and Cancer Diagnostics; raises FY26 EPS guidance.